[1]杜丽君.穴位埋线疗法联合口服美沙拉嗪治疗溃疡性结肠炎的 护理分析[J].医学信息,2018,31(05):172-173.[doi:10.3969/j.issn.1006-1959.2018.05.063]
　DU Li-jun.Nursing Analysis of Acupoint Catgut Embedding Therapy Combined with Oral Mesalazine in the Treatment of Ulcerative Colitis[J].Journal of Medical Information,2018,31(05):172-173.[doi:10.3969/j.issn.1006-1959.2018.05.063]
点击复制

穴位埋线疗法联合口服美沙拉嗪治疗溃疡性结肠炎的 护理分析()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
31卷
期数:
2018年05期
页码:
172-173
栏目:
护理研究
出版日期:
2018-03-01

文章信息/Info

Title:
Nursing Analysis of Acupoint Catgut Embedding Therapy Combined with Oral Mesalazine in the Treatment of Ulcerative Colitis
文章编号:
1006-1959（2018）05-0172-02
作者:
杜丽君
东南大学医学院附属江阴医院消化科，江苏 江阴 214400
Author(s):
DU Li-jun
Department of Digestive Sciences,Jiangyin Hospital,Medical College of Southeast University,Jiangyin 214400,Jiangsu,China
关键词:
穴位埋线; 溃疡性结肠炎;  护理干预
Keywords:
Key words：Acupoint catgut embedding; Ulcerative colitis; Nursing intervention
分类号:
R473.5
DOI:
10.3969/j.issn.1006-1959.2018.05.063
文献标志码:
A
摘要:
目的 分析探讨护理干预对穴位埋线疗法联合口服美沙拉嗪治疗溃疡性结肠炎患者的作用。 方法 选取我院2010年8月～2013年3月诊治的位于UC缓解期1周的患者62例，随机分为美沙拉嗪组32例与美沙拉嗪联合穴位埋线治疗组(30例)联合治疗组(30例)采用穴位埋线疗法并予美沙拉嗪口服，同时给予实施综合护理干预。观察美沙拉嗪组及联合治疗组12个月后的缓解时长、复发率以及不良反应情况。结果 美沙拉嗪组、联合治疗组复发率分别为13（40.6％）、5（16.7％），两组相比较P<0．05；联合治疗组的缓解时间(260±67) d比美沙拉嗪组的缓解时间(219±77) d相对较长，差异有统计学意义（P<0．05）。结论 护理干预对穴位埋线疗法同时使用美沙拉嗪来治疗溃疡性结肠炎有积极意义，有利于减少病情复发，提高患者的生活质量。
Abstract:
Abstract：Objective To analyze the effect of nursing intervention on patients with ulcerative colitis treated by acupoint catgut embedding therapy combined with oral mesalazine.Methods In our hospital from August 2010 to March 2013 in the diagnosis and treatment of UC remission in 62 cases 1 weeks were randomly divided into the group of 32 cases and beauty of salad combined with acupoint catgut embedding therapy group(30 cases)and treatment group(30 cases)and treated with acupoint catgut embedding therapy with oral beauty of salad,and give the implementation of comprehensive nursing intervention.The length,recurrence rate and adverse reaction of mesalazine group and combined treatment group were observed after 12 months.Results The salad diazoxide group and combined treatment group recurrence rate was 13(40.6%),5(16.7%),compared with the two groups of P<0.05;the remission time of combined treatment group(260±67)d Bimei salad group remission time(219±77)d is relatively long, the difference was statistically significant(P<0.05).Conclusion Nursing intervention has a positive effect on catgut embedding therapy and mesalazine in the treatment of ulcerative colitis,which helps to reduce the recurrence and improve the quality of life of patients.

参考文献/References:

[1]柴娟娟.中西医结合治疗溃疡性结肠炎临床疗效观察[J].临床医学研究与实践,2017,(23):104-105. [2]干丹,韩昌鹏.中西医结合治疗溃疡性结肠炎的研究进展[J]. 现代中西医结合杂志,2017,(26):2958-2961.

相似文献/References:

[1]李羞月.穴位埋线治疗慢性荨麻疹的中医护理对策及效果观察[J].医学信息,2018,31(02):177.[doi:10.3969/j.issn.1006-1959.2018.02.069]
　LI Xiu-yue.Nursing Countermeasures and Effect Observation of Acupoint Catgut Embedding Therapy for Chronic Urticaria[J].Journal of Medical Information,2018,31(05):177.[doi:10.3969/j.issn.1006-1959.2018.02.069]
[2]张君红,李洪梅,井 洁,等.溃疡性结肠炎中西医结合治疗研究[J].医学信息,2018,31(09):59.[doi:10.3969/j.issn.1006-1959.2018.09.019]
　ZHANG Jun-hong,LI Hong-mei,JING Jie,et al.Study on the Treatment of Ulcerative Colitis with Integrated Traditional Chinese and Western Medicine[J].Journal of Medical Information,2018,31(05):59.[doi:10.3969/j.issn.1006-1959.2018.09.019]
[3]李 伟,徐 伟.溃疡性结肠炎中医干预治疗研究[J].医学信息,2022,35(09):62.[doi:10.3969/j.issn.1006-1959.2022.09.015]
　LI Wei,XU Wei.Study on Traditional Chinese Medicine Intervention Treatment of Ulcerative Colitis[J].Journal of Medical Information,2022,35(05):62.[doi:10.3969/j.issn.1006-1959.2022.09.015]
[4]汤胜男,赵党生,王凤仪,等.芍药汤治疗溃疡性结肠炎的研究[J].医学信息,2019,32(15):3.[doi:10.3969/j.issn.1006-1959.2019.15.002]
　TANG Sheng-nan,ZHAO Dang-sheng,WANG Feng-yi,et al.Study on Treating Ulcerative Colitis with Shaoyao Decoction[J].Journal of Medical Information,2019,32(05):3.[doi:10.3969/j.issn.1006-1959.2019.15.002]
[5]宋 崟,张 科.基于生物信息学方法探究溃疡性结肠炎的关键基因和通路[J].医学信息,2022,35(16):13.[doi:10.3969/j.issn.1006-1959.2022.16.003]
　SONG Yin,ZHANG Ke.Key Genes and Pathways of Ulcerative Colitis Based on Bioinformatics[J].Journal of Medical Information,2022,35(05):13.[doi:10.3969/j.issn.1006-1959.2022.16.003]
[6]华 琳,陈元旺,唐 静,等.溃疡性结肠炎患者外周血Tim-4 mRNA表达水平的变化及意义[J].医学信息,2019,32(21):161.[doi:10.3969/j.issn.1006-1959.2019.21.054]
　HUA Lin,CHEN Yuan-wang,TANG Jing,et al.Changes and Significance of Tim-4 mRNA Expression in Peripheral Blood of Patients with Ulcerative Colitis[J].Journal of Medical Information,2019,32(05):161.[doi:10.3969/j.issn.1006-1959.2019.21.054]
[7]徐 杰.美沙拉嗪与柳氮磺吡啶治疗溃疡性结肠炎的效果比较[J].医学信息,2020,33(04):151.[doi:10.3969/j.issn.1006-1959.2020.04.049]
　XU Jie.Comparison of Mesalazine and Sulfasalazine in Treating Ulcerative Colitis[J].Journal of Medical Information,2020,33(05):151.[doi:10.3969/j.issn.1006-1959.2020.04.049]
[8]牙韩清,郑琴芳,何志钧.溃疡性结肠炎相关结直肠癌手术治疗现况[J].医学信息,2020,33(07):44.[doi:10.3969/j.issn.1006-1959.2020.07.014]
　YA Han-qing,ZHENG Qin-fang,HE Zhi-jun.Surgical Treatment of Ulcerative Colitis-related Colorectal Cancer[J].Journal of Medical Information,2020,33(05):44.[doi:10.3969/j.issn.1006-1959.2020.07.014]
[9]王莹洁,戴迟兵.益生菌在炎症性肠病中的应用研究[J].医学信息,2020,33(22):42.[doi:10.3969/j.issn.1006-1959.2020.22.013]
　WANG Ying-jie,DAI Chi-bing.Study on the Application of Probiotics in Inflammatory Bowel Disease[J].Journal of Medical Information,2020,33(05):42.[doi:10.3969/j.issn.1006-1959.2020.22.013]
[10]朱 燕,刘大铭,刘全喜,等.溃疡性结肠炎中医诊疗思路[J].医学信息,2021,34(03):167.[doi:10.3969/j.issn.1006-1959.2021.03.048]
　ZHU Yan,LIU Da-ming,LIU Quan-xi,et al.TCM Diagnosis and Treatment of Ulcerative Colitis[J].Journal of Medical Information,2021,34(05):167.[doi:10.3969/j.issn.1006-1959.2021.03.048]

更新日期/Last Update: 2018-03-01